March 31 – April 3, 2019
Atlanta, Georgia
Details:
Exhibition booth #4322
Satellite symposium: Biomarker-driven Precision Oncology | March 31, 2019
Poster Presentations:
- Prognostic and predictive utility of copy number variations (CNVs) in circulating tumor DNA (ctDNA) from metastatic castration-resistant prostate cancer (mCRPC) patients https://www.abstractsonline.com/pp8/#!/6812/presentation/4859
- Combined immunohistochemistry and NGS-based patient profiling for predicting anti-PD-1/PD-L1 therapy response https://www.abstractsonline.com/pp8/#!/6812/presentation/4962
- Development and validation of PredicineATLAS, a 600-gene liquid biopsy panel for simultaneous detection of TMB and genomic alterations in Immuno-Oncology
https://www.abstractsonline.com/pp8/#!/6812/presentation/5069 - Development and validation of urine cfDNA preservative kit for detection of genomic alterations in cancer
https://www.abstractsonline.com/pp8/#!/6812/presentation/5091 - Development and validation of liquid biopsy assay for copy number loss in cancers
https://www.abstractsonline.com/pp8/#!/6812/presentation/4923